Digital Health | pharmaphorum

Skip to main content

Saturday 21 February 2026

BlueSky linkedin youtube

header links

Get Newsletters
Media Kit

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
Spotlight on
Events

close

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

youtube linkedin BlueSky

Digital Health

Healthcare

Velocity Health1

MSD and Wayra to fund UK digital health start-ups

Big pharma company Merck Sharp & Dohme is teaming up with Wayra UK to offer more start-up funds for new digital health companies in the UK.

News

AI in pharma and healthcare

Change Healthcare, Google aim to create faster imaging tech

Partnership will use AI to create faster imaging devices

News

GE Revolution Frontier

GE Healthcare and NVIDIA use AI to boost health data process...

Companies have struck a 10-year partnership.

News

Close up view of young woman holding ginseng vitamins and minerals pills in hand with capsule bottle on table. High angle view

Experimental opioid digital pill successful in early trial

Digital opioid pill successfully tracks adherence but reveals worrying behaviour among opioid-naive patients.

News

lillyhq

Lilly looks to devices to revive diabetes division

Dexcom continuous glucose monitors to become part of Lilly's Connected Devices Ecosystem.

News

Phillip Hammond

Budget 2017: Artificial Intelligence funds welcome, but bold...

UK AI leader welcomes increased investment but suggests more needs to be done.

Load more results

Editor's Picks

Hudson out at Sanofi, as Belén Garijo named CEO

Lilly strikes $8.8bn-plus alliance with China's Innovent

Euro VCs team up to invigorate life sciences ecosystem

Moderna cries foul as FDA blocks filing of mRNA flu shot

Novo Nordisk rises as Hims & Hers backs down on oral GLP-1

News

Bone structure

FDA starts review of Regeneron's drug for rare disease FOP

Can Regeneron's drug for ultra-rare bone disease FOP pick up the baton from Ipsen's Sohonos, whose growth has stalled?

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

Sponsored

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Get Newsletters

youtube linkedin BlueSky

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company